About us
A world class team at the forefront of a new approach to treating chronic diseases.
Scientists at heart, with almost 1000 years of combine drug discovery and development expertise, we are the only company to understand and exploit the body’s natural biology of repair. We aim to do more than provide incremental or marginal benefits over current standards of care. Our investigational drugs are first-in-class with a unique mode of action; they work by turning on the body’s ‘repair switch’ enabling the repair of damaged tissue and restoring tissue architecture to its original form.
That’s why we called our company Istesso, from ‘a l’istesso tempo’, a musical phrase meaning to play at the same tempo as before. We want our treatments to help return people to how they were before their illness.
Everything we do is underpinned by our core values: to create possibilities, respond to needs, and develop bold solutions. These values define our culture and guide our work, putting the power of science and its real-life impact at the heart of everything we do. We are committed to making a difference in the lives of patients and their families by developing medicines with the potential to revolutionise treatment.
Team
Sam Williams
Chairman
Lisa Patel
Chief Executive Officer
Patrick Round
Chief Medical Officer
Chris Hill
Chief Financial Officer
Gemma Vallance
Operations Manager
David Loczenski
Project Manager
Dhammy Parameswaran
Project Manager
Board
Sam Williams
Chairman
Lisa Patel
Chief Executive Officer
Peter Allen
None-Executive Director
Professor Sir Keith Peters
Non-Executive Director
Craig Richardson
Observer
Greg Smith
Observer
